Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten van Lemmen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
British Journal of Anaesthesia|January 8, 2022
Buprenorphine: a treatment and cause of opioid-induced respiratory depressionAlbert Dahan, Maarten van Lemmen, Simone Jansen, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2023
Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humansMaarten van Lemmen, Rutger van der Schrier, Albert Dahan, et al.
Anesthesiology|August 7, 2025
Fentanyl-induced ventilatory depression: population pharmacokinetic/ pharmacodynamic framework for evaluation of opioid-induced ventilatory depressionMaarten van Lemmen, Erik Olofsen, Monique van Velzen, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|August 29, 2022
<i>S</i>-Ketamine oral thin film-Part 2: Population pharmacodynamics of <i>S</i>-ketamine, <i>S</i>-norketamine and <i>S</i>-hydroxynorketaminePieter Simons, Erik Olofsen, Monique van Velzen, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|July 28, 2022
<i>S</i>-Ketamine Oral Thin Film-Part 1: Population Pharmacokinetics of <i>S</i>-Ketamine, <i>S</i>-Norketamine and <i>S</i>-HydroxynorketaminePieter Simons, Erik Olofsen, Monique van Velzen, et al.
Anesthesiology|July 4, 2023
Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac ArrestMaarten van Lemmen, Jeffrey Florian, Zhihua Li, et al.
Anesthesiology|February 9, 2024
Naloxone for Opioid Overdose: ReplyMaarten van Lemmen, Jeffrey Florian, Zhihua Li, et al.
Anesthesiology|January 19, 2024
Reversal of Propofol-induced Depression of the Hypoxic Ventilatory Response by BK-channel Blocker ENA-001: A Randomized Controlled TrialSimone C Jansen, Maarten van Lemmen, Erik Olofsen, et al.
British Journal of Anaesthesia|February 1, 2023
Inhaled Δ<sup>9</sup>-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteersCornelis Jan van Dam, Rutger van der Schrier, Monique van Velzen, et al.
Anesthesiology|December 20, 2022
Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with MorphinePieter Simons, Rutger van der Schrier, Maarten van Lemmen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Anaesthesia|January 8, 2022
Buprenorphine: a treatment and cause of opioid-induced respiratory depressionAlbert Dahan, Maarten van Lemmen, Simone Jansen, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2023
Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humansMaarten van Lemmen, Rutger van der Schrier, Albert Dahan, et al.
Anesthesiology|August 7, 2025
Fentanyl-induced ventilatory depression: population pharmacokinetic/ pharmacodynamic framework for evaluation of opioid-induced ventilatory depressionMaarten van Lemmen, Erik Olofsen, Monique van Velzen, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|August 29, 2022
<i>S</i>-Ketamine oral thin film-Part 2: Population pharmacodynamics of <i>S</i>-ketamine, <i>S</i>-norketamine and <i>S</i>-hydroxynorketaminePieter Simons, Erik Olofsen, Monique van Velzen, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|July 28, 2022
<i>S</i>-Ketamine Oral Thin Film-Part 1: Population Pharmacokinetics of <i>S</i>-Ketamine, <i>S</i>-Norketamine and <i>S</i>-HydroxynorketaminePieter Simons, Erik Olofsen, Monique van Velzen, et al.
Anesthesiology|July 4, 2023
Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac ArrestMaarten van Lemmen, Jeffrey Florian, Zhihua Li, et al.
Anesthesiology|February 9, 2024
Naloxone for Opioid Overdose: ReplyMaarten van Lemmen, Jeffrey Florian, Zhihua Li, et al.
Anesthesiology|January 19, 2024
Reversal of Propofol-induced Depression of the Hypoxic Ventilatory Response by BK-channel Blocker ENA-001: A Randomized Controlled TrialSimone C Jansen, Maarten van Lemmen, Erik Olofsen, et al.
British Journal of Anaesthesia|February 1, 2023
Inhaled Δ<sup>9</sup>-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteersCornelis Jan van Dam, Rutger van der Schrier, Monique van Velzen, et al.
Anesthesiology|December 20, 2022
Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with MorphinePieter Simons, Rutger van der Schrier, Maarten van Lemmen, et al.
Pageof 2